Louisbourg Investments’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.95M Buy
182,953
+98,866
+118% +$5.37M 1.1% 31
2026
Q1
$3.97M Buy
84,087
+76,220
+969% +$6.1M 0.75% 60
2025
Q4
$585K Buy
7,867
+587
+8% +$57.5K 0.12% 106
2025
Q3
$535K Hold
7,280
0.12% 100
2025
Q2
$599K Sell
7,280
-1,250
-15% -$126K 0.14% 95
2025
Q1
$664K Sell
8,530
-4,605
-35% -$464K 0.18% 92
2024
Q4
$887K Hold
13,135
0.23% 84
2024
Q3
$872K Hold
13,135
0.22% 82
2024
Q2
$794K Sell
13,135
-8,575
-39% -$628K 0.22% 81
2024
Q1
$1.17M Sell
21,710
-13,600
-39% -$874K 0.33% 73
2023
Q4
$1.62M Buy
+35,310
New +$1.88M 0.49% 64

Other funds holding BSX

Louisbourg Investments's BSX Position: Q2 2026 in Review

Louisbourg Investments increased its Boston Scientific (BSX) stake by 118% in Q2 2026, buying an estimated $5.37M and bringing the position to 182,953 shares worth $5.95M. The position accounts for 1.1% of the portfolio, ranked #31.

Louisbourg Investments first reported a position in BSX in Q4 2023 and has held it in 11 quarters since. 848 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Louisbourg Investments held 182,953 shares of Boston Scientific worth $5.95M as of Q2 2026.
  • Louisbourg Investments bought 98,866 Boston Scientific shares in Q2 2026, an estimated $5.37M.
  • Boston Scientific made up 1.1% of Louisbourg Investments's portfolio in Q2 2026, its #31 holding.
  • Louisbourg Investments first reported a position in Boston Scientific in Q4 2023 and has held it in 11 quarters since.
  • 848 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Louisbourg Investments's 13F filing for Q2 2026, filed 23 Jul 2026.